Ken Melillo

Ken Melillo is an experienced professional in global quality management and compliance, currently serving as the Director of Global Quality Management at AbbVie since August 2024. Prior to this role, Melillo held the same title at Cerevel Therapeutics from November 2022 to August 2024 and has held various leadership positions in quality assurance, including Director GVP Research QA at Akebia Therapeutics and Director of Quality Management Systems and Compliance at Akcea Therapeutics. Melillo's career includes significant roles at Takeda, Shire, Genzyme Corporation, and Teradyne Inc., showcasing expertise in quality systems, risk analytics, and compliance. Melillo holds a Bachelor of Science in Industrial Engineering from Northeastern University and an MBA in Operations from Suffolk University - Sawyer Business School.